Related Experiment Video

Updated: Jul 16, 2026

Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification
10:21

Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification

Published on: September 20, 2024

PMN degranulation in relation to CD63 expression and genetic polymorphisms in healthy individuals and COPD patients

X Z Zhang1, P D Paré, A J Sandford

  • 1James Hogg iCAPTURE Centre for Cardiovascular and Pulmonary Research, St Paul's Hospital, University of British Columbia, Vancouver, BC, Canada.

International Journal of Molecular Medicine
|March 29, 2007
PubMed

Insights

Chronic obstructive pulmonary disease (COPD) patients show reduced CD63 expression and myeloperoxidase (MPO) release from neutrophils. Genetic variations in CD63 did not significantly impact expression but influenced MPO release in healthy individuals.

Area of Science:

  • Immunology
  • Genetics
  • Pulmonology

Background:

  • Polymorphonuclear neutrophils (PMNs) are crucial in chronic obstructive pulmonary disease (COPD) pathogenesis.
  • The tetraspanin CD63, a marker of azurophilic granules, regulates PMN endocytosis and exocytosis.

Purpose of the Study:

  • To investigate CD63 gene polymorphisms, CD63 expression, and PMN myeloperoxidase (MPO) release in COPD patients and healthy individuals.
  • To evaluate correlations between CD63 genetic polymorphisms, CD63 expression, and MPO release.

Main Methods:

  • Investigated eleven putative CD63 gene polymorphisms.
  • Quantified CD63 expression and MPO release in PMNs from healthy subjects and COPD patients upon chemokine stimulation.
  • Assessed associations between polymorphisms, CD63 expression, and MPO release.

Main Results:

  • COPD patients exhibited significantly lower CD63 expression and MPO release compared to healthy individuals.
  • No CD63 polymorphisms were associated with CD63 expression in either group.
  • The 8041C/G polymorphism (3' to CD63) correlated with MPO release in healthy subjects (CC genotype showed higher MPO release than GG genotype).

Conclusions:

  • COPD patients display distinct patterns of CD63 expression and PMN mediator release compared to healthy individuals.
  • Genetic variants appear to have a limited role in modulating CD63 expression and MPO release in COPD.
  • Further research is needed to determine the role of CD63 genetic variants in other diseases.

More Related Videos

Isolation and Characterization of Neutrophil-derived Microparticles for Functional Studies06:56

Isolation and Characterization of Neutrophil-derived Microparticles for Functional Studies

Published on: March 2, 2018

Related Concept Videos

Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...